US Physical Therapy grants director 2,306 shares

Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Bernard A. Harris Jr. received 2,306 shares of common stock as a restricted stock award. The shares were granted at a reference price of $61.61 per share under the Company Amended and Restated 2003 Stock Incentive Plan. Following this grant, he directly holds 20,914 shares.

The award vests over time if he continues serving as a director. Restrictions lapse on 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, conditioned on his board service on those dates.

Insider Trade Summary

Grant/Award: 2,306 shares

Grant/Award 1 txn

Insider Harris Bernard A Jr

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,306	$61.61	$142K

Holdings After Transaction: Common Stock — 20,914 shares (Direct)

Footnotes (1)

1. F1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Key Figures

Restricted shares granted: 2,306 shares Grant price: $61.61 per share Shares held after grant: 20,914 shares +3 more

6 metrics

Restricted shares granted 2,306 shares Common Stock award to director on May 19, 2026

Grant price $61.61 per share Reference price for restricted stock award

Shares held after grant 20,914 shares Director’s direct common stock holdings post-transaction

First vesting tranche 1,153 shares Restrictions lapse on August 20, 2026 if still a director

Second vesting tranche 576 shares Restrictions lapse on November 20, 2026 if still a director

Third vesting tranche 577 shares Restrictions lapse on March 6, 2027 if still a director

Key Terms

restricted stock, Stock Incentive Plan, restrictions lapse

3 terms

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Incentive Plan financial

"pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.

restrictions lapse financial

"Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did U.S. Physical Therapy (USPH) report for Bernard A. Harris Jr.?

U.S. Physical Therapy reported that director Bernard A. Harris Jr. received 2,306 shares of common stock as a restricted stock grant. This compensation award increased his direct holdings to 20,914 shares, according to the Form 4 filing and its related footnote disclosure.

What type of shares did Bernard A. Harris Jr. receive from U.S. Physical Therapy (USPH)?

He received 2,306 shares of U.S. Physical Therapy common stock as restricted stock under the Company Amended and Restated 2003 Stock Incentive Plan. These shares are subject to vesting conditions and do not all become fully owned immediately upon grant.

At what price was the U.S. Physical Therapy (USPH) restricted stock grant recorded?

The restricted stock grant to Bernard A. Harris Jr. was recorded at $61.61 per share. This price reflects the grant-date value for reporting purposes and does not represent an open-market purchase or sale by the director.

How many U.S. Physical Therapy (USPH) shares does Bernard A. Harris Jr. hold after this grant?

After receiving the 2,306 restricted shares, Bernard A. Harris Jr. directly holds 20,914 shares of U.S. Physical Therapy common stock. This total includes the newly granted restricted stock, which will vest over time if service conditions are met.

When do the U.S. Physical Therapy (USPH) restricted shares granted to Bernard A. Harris Jr. vest?

The restrictions lapse in three tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027. Vesting requires that he remains a director on each respective date.

Is the U.S. Physical Therapy (USPH) Form 4 transaction a market purchase or sale?

No, the Form 4 transaction reflects a grant of restricted stock as director compensation, not an open-market purchase or sale. The filing classifies it as a grant, award, or other acquisition of 2,306 shares under the company’s stock incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harris Bernard A Jr

(Last) (First) (Middle)

3333 ALLEN PARKWAY #1709

(Street)

HOUSTON TEXAS 77019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		2,306	A	$61.61	20,914(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

	/s/ Kate Venturina, as attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)